EP 1750701 A1 20070214 - AMORPHOUS CLOPIDOGREL HYDROCHLORIDE AND ITS ANTITHROMBOTIC USE
Title (en)
AMORPHOUS CLOPIDOGREL HYDROCHLORIDE AND ITS ANTITHROMBOTIC USE
Title (de)
AMORPHES CLOPIDOGREL-HYDROCHLORID UND SEINE ANTITHROMBOTISCHE ANWENDUNG
Title (fr)
HYDROCHLORURE DE CLOPIDOGREL AMORPHE ET SON UTILISATION EN TANT QU'ANTITHROMBOTIQUE
Publication
Application
Priority
- US 2005019326 W 20050601
- GB 0412172 A 20040601
- GB 0418395 A 20040818
Abstract (en)
[origin: WO2005117866A1] The invention provides methyl (+)-(S)-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate hydrochloride in amorphous form, processes for the preparation of the amorphous form and a pharmaceutical composition containing the amorphous form. The amorphous form is useful as a blood platelet aggregation inhibitor and as an antithrombotic agent.
IPC 8 full level
A61K 31/4365 (2006.01); A61P 9/00 (2006.01); C07D 495/04 (2006.01)
CPC (source: EP)
A61P 9/00 (2017.12); C07D 495/04 (2013.01)
Citation (search report)
See references of WO 2005117866A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005117866 A1 20051215; EP 1750701 A1 20070214; IL 179717 A0 20070515
DOCDB simple family (application)
US 2005019326 W 20050601; EP 05756511 A 20050601; IL 17971706 A 20061130